Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Palliative Radiotherapy for Locally Advanced Hepatocellular Carcinoma and Hepatic Metastases

NCT00923897 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00923897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00923897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Palliative Radiotherapy for Locally Advanced Hepatocellular Carcinoma and Hepatic Metastases
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
September 26, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic metastasis, hepatocellular carcinoma